PPARGC1B and cystic fibrosis: To this end, our findings suggest a more general role for PGC-1β in skeletal muscle metabolism, and possibly in the progression of chronic infection [62], in addition to the insulin resistance seen in obese and/or type 2 diabetic patients [48], [49], [63], and CF patients with a high incidence of diabetes [25].